Ignite Creation Date:
2024-05-06 @ 11:06 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03433183
Status:
COMPLETED
Last Update Posted:
2023-12-26
First Post:
2018-01-29
Brief Title:
SARC031 MEK Inhibitor Selumetinib AZD6244 in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
Sponsor:
Organization:
Sarcoma Alliance for Research through Collaboration